B.H. Rovin - Concepedia

Author

B.H. Rovin

The Ohio State University

Also Known As

B H Rovin, B. H. Rovin, B. Rovin, B.H. Rovin, BH Rovin

Publications

Citations

H-Index

Concepts

All Affiliations

The Ohio State University The Ohio State University Wexner Medical Center

About

B.H. Rovin is an author at The Ohio State University specializing in immune regulation, autoimmunity, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	44
2	Cell Biology	2	2	44
3	Immunology	2	2	44
4	Autoimmune Disease	2	2	44
5	Allergy	1	1	28

B.H. Rovin

Publications

581

Citations

H-Index

Page 1

	Year	Citations
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare DJ Birmingham, Fawzi I. Irshaid, HN Nagaraja, Lupus	2010	187
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q CC Mok, DJ Birmingham, LY Ho, Lupus	2011	119
The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients AS Alvarado, Ana Malvar, Bruno Lococo, Lupus	2014	95
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans DJ Birmingham, LA Hebert, Huijuan Song, Lupus	2012	54
Predicting decline of kidney function in lupus nephritis using urine biomarkers Khalid Abulaban, Huijuan Song, X. Zhang, Lupus	2016	41
Lymphocytes produce IL-1beta in response to Fcgamma receptor cross-linking: effects on parenchymal cell IL-8 release. CB Marsh, M P Lowe, B.H. Rovin, PubMed Macrophage Il-8 ReleaseImmunologyImmune RegulationImmunologic MechanismImmune System	1998	28
Oral Warfarin and the Thrombin Inhibitor Dabigatran Increase Blood Pressure in Rats: Hidden Danger of Anticoagulants? Kyle Ware, J. C. Vance, Navin Muni, American Journal of Hypertension	2014	25
Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta. B.H. Rovin, Ling Lu, CB Marsh PubMed ImmunologyRenal InflammationImmune RegulationImmunologic MechanismImmune System	2001	16
POS0690 RANDOMIZED, CONTROLLED, PHASE 2 TRIAL OF TYPE 1 IFN INHIBITOR ANIFROLUMAB IN PATIENTS WITH ACTIVE PROLIFERATIVE LUPUS NEPHRITIS David Jayne, B.H. Rovin, Eduardo Mysler, Annals of the Rheumatic Diseases	2021	16

Page 1